Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

This study is currently recruiting participants.
Verified September 2012 by Nova Laboratories Limited
Sponsor:
Information provided by (Responsible Party):
Nova Laboratories Limited
ClinicalTrials.gov Identifier:
NCT01697020
First received: September 20, 2012
Last updated: September 26, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)